Covered recipient · General Payments record
FATIMA JALIL
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$738.67
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.15 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $79.55 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.57 | 2 |
| Lilly USA, LLC | $35.85 | 2 |
| Xeris Pharmaceuticals, Inc. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.59 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125087526 | CMS |
| Abbott Laboratories | $16.53 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125087528 | CMS |
| Abbott Laboratories | $15.47 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125087530 | CMS |
| Abbott Laboratories | $24.96 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125087532 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.29 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118027757 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.28 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118027755 | CMS |
| Lilly USA, LLC | $19.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134975852 | CMS |
| Lilly USA, LLC | $16.50 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972473 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144594546 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.